Drug Shortages In Healthcare

804 Words2 Pages

For more than a decade America has struggled and continues to struggle with reducing and eventually eliminating drug shortages. According to the FDA, drug shortages are defined as a situation in which the total supply of all clinically interchangeable versions of FDA-regulated drugs is inadequate to meet current demand at the patient level. Consequently, throughout the years various stake and shareholders have experienced a roller coaster ride, some tremendously affected by high spikes of drug shortages, while others are fortunate that the numbers remain low. Unfortunately, drug shortages produce numerous barriers for manufactures, patients, doctors, investors, and the health care organizations. For example, manufacturers face the pressures …show more content…

In response to the tremendous increase of drug shortages in 2011, an executive order 13588 was constructed in order to prevent future prescription drug shortages. Soon followed by new policies and procedures implemented through the FDA, known as the Safety and Innovation Act, Strategic Plan to Mitigate Shortages, and the Final Rule created on July 8, 2015. Below will discuss a brief overview of each policy implemented by the FDA in the third annual reports to Congress.
FDA Policies and Procedures for Drug Shortages

Causes and Effect of Drug Shortages
Various factors play a part in why drug shortages occur, some instances are inevitable. For instance, when a natural disaster hits, protecting drugs, are equally important as protecting lives, which in many cases are impossible. In this event, thousands of drugs can be damaged and ruined. In addition, other shortages occur from the production from an offset of supply and demand, which accounts for an approximated 13% of …show more content…

Accordingly, death is a major concern, and has come as a consequence of the absence of appropriate drugs needed for treatment. Ventola (2011) reported, “Drug shortages can affect the ability of health care professionals to keep patients alive, particularly in emergency departments, intensive-care units, and oncology wards” (p. 751). Furthermore, multiple reported deaths have been associated to drug shortages. For this reason, alternative treatments are not an option for everyone, and can require days of hospital inpatient care, such as cancer patients who can’t receive chemotherapy. On the other hand, pharmacist and providers are working three times as hard to provide patients with alternative treatment methods that can be pricey. According to Fox (2014), “The economic effect can also be felt by patients when the formulary preferred agent on their managed care plan becomes unavailable and a more costly alternative must be prescribed” (Fox et al, p 365). Many alternative prescriptions are available due to the rationing of drugs. As a result, patients have an adequate measure to stabilize, and in some cases treat their condition. Lastly, safety risk is another health hazard that adversely affects patients and puts a strain on professional relationship. Alternatives are not always the best options, and in some cases cause significant damage. As reported by Ventola (2011), “A shortage often

Open Document